GlaxoSmithKline reaches agreement to divest majority of Classic Brands in Australia for £172m
15 August 2012 | By GlaxoSmithKline
GSK has reached agreement to divest the majority of its “Classic Brands” in Australia...
List view / Grid view
News
Boehringer Ingelheim achieves further growth in first half of 2012
14 August 2012 | By Boehringer Ingelheim
Boehringer Ingelheim has grown again in the current financial year...
Patheon announces a change to its PDS management structure
13 August 2012 | By Patheon
Patheon Inc. announced that Mark J. Kontny is no longer with the company...
Sanofi announces FDA approval for Auvi-Q™
13 August 2012 | By Sanofi
Breakthrough device design talks patients and caregivers through the injection process...
Public voting now open to help grant two $20,000 Abbott CFCareForward Scholarships to students with CF
13 August 2012 | By Abbott
40 students living with CF each to receive a $2,500 CFCareForward Scholarship...
FDA approves Lucentis (ranibizumab injection) for treatment of diabetic macular edema
13 August 2012 | By Roche
First major treatment advance in more than 25 years for sight-threatening condition...
AstraZeneca and Pfizer enter agreement for over-the-counter NEXIUM; AstraZeneca raises 2012 guidance
13 August 2012 | By AstraZeneca
NEXIUM 20mg retail launch targeted for 2014, subject to regulatory approval...
Pfizer reports results from Phase 3 study of Torisel (temsirolimus)
10 August 2012 | By Pfizer
Pfizer Inc. announced the Phase 3 INTORACT trial (B1771006) did not meet its primary endpoint...
Adding Avastin to radiation and chemotherapy extends the time people with an aggressive form of brain cancer lived without their disease worsening
10 August 2012 | By Roche
Phase III study met its co-primary endpoint...
New SPE accessories hold tubes in 96-well spacing for automated applications
9 August 2012 | By Phenomenex Inc
Phenomenex introduces two new Tabless Tube Holder accessories...
AstraZeneca and Bristol-Myers Squibb complete expansion of diabetes alliance
9 August 2012 | By AstraZeneca
AstraZeneca has made an initial payment of approximately $3.2 billion to Amylin Pharmaceuticals...
Novo Nordisk increased operating profit by 31% in the first half of 2012
9 August 2012 | By Novo Nordisk
Sales grew 17% driven by Victoza®, NovoRapid® and Levemir®...
Nodality enters into a multi-year strategic collaboration with Pfizer in autoimmune disease
9 August 2012 | By Pfizer
Nodality, Inc.has announced a strategic collaboration with Pfizer Inc..
Lundbeck on track to meet financial expectations and renew its product portfolio to secure long-term growth
8 August 2012 | By H. Lundbeck A/S
H. Lundbeck A/S reports first half revenue of DKK 6,829 million...
Teva to initiate Third Phase III Trial of oral laquinimod for the treatment of relapsing remitting multiple sclerosis
8 August 2012 | By Teva Pharmaceutical Industries Ltd
The clinical trial protocol has been granted a Special Protocol Assessment agreement...
